5-methylurapidil has been researched along with Hypertrophy, Right Ventricular in 1 studies
Hypertrophy, Right Ventricular: Enlargement of the RIGHT VENTRICLE of the heart. This increase in ventricular mass is often attributed to PULMONARY HYPERTENSION and is a contributor to cardiovascular morbidity and mortality.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In rats, injection of monocrotaline (MCT) causes pulmonary hypertension that leads to right ventricular failure." | 3.71 | Changes in alpha(1)-adrenergic vascular reactivity in monocrotaline-treated rats. ( Brodde, OE; Dhein, S; Giessler, C; Heinroth-Hoffmann, I; Leineweber, K; Seyfarth, T, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dhein, S | 1 |
| Giessler, C | 1 |
| Heinroth-Hoffmann, I | 1 |
| Leineweber, K | 1 |
| Seyfarth, T | 1 |
| Brodde, OE | 1 |
1 other study available for 5-methylurapidil and Hypertrophy, Right Ventricular
| Article | Year |
|---|---|
Changes in alpha(1)-adrenergic vascular reactivity in monocrotaline-treated rats.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agon | 2002 |